Deferred Tax Assets, Valuation Allowance of Lexaria Bioscience Corp. from 31 Aug 2016 to 31 Aug 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary: Lexaria Bioscience Corp. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Aug 2016 to 31 Aug 2025.
Lexaria Bioscience Corp. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Aug 2025 was $13,412,448, a 25% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Lexaria Bioscience Corp. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$13,412,448	+$2,681,172	+25%	31 Aug 2025	10-K	28 Nov 2025	2025	FY
Q3 2024	$10,731,276	+$1,150,439	+12%	31 Aug 2024	10-K	28 Nov 2025	2025	FY
Q3 2023	$9,580,837			31 Aug 2023	10-K	26 Nov 2024	2024	FY
Q3 2018	$4,124,662	-$443,258	-9.7%	31 Aug 2018	10-K	14 Nov 2018	2018	FY
Q3 2017	$4,567,920	+$608,216	+15%	31 Aug 2017	10-K	14 Nov 2018	2018	FY
Q3 2016	$3,959,704			31 Aug 2016	10-K	14 Nov 2018	2018	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.